Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
J Pharmacol Exp Ther. 2012 Jan;340(1):73-82. doi: 10.1124/jpet.111.185728. Epub 2011 Oct 7.
3,4-Methylenedioxymethamphetamine (MDMA) is known to enhance tactile sensory perception, an effect that contributes to its popularity as a recreational drug. The neurophysiological basis for the effects of MDMA on somatosensation are unknown. However, MDMA interactions with the serotonin transporter (SERT) and subsequent enhancement of serotonin neurotransmission are well known. The rat trigeminal somatosensory system receives serotonergic afferents from the dorsal raphe nucleus. Because these fibers express SERT, they should be vulnerable to MDMA-induced effects. We found that administration of a challenge injection of MDMA (3 mg/kg i.p.) after repeated MDMA treatment (3 mg/kg per day for 4 days) elicits both serotonin and norepinephrine efflux in the ventral posterior medial (VPM) thalamus of Long-Evans hooded rats, the main relay along the lemniscal portion of the rodent trigeminal somatosensory pathway. We evaluated the potential for repeated MDMA administration to modulate whisker-evoked discharge of individual neurons in this region. After surgically implanting stainless steel eight-wire multichannel electrode bundles, we recorded spike train activity of single cells while activating the whisker pathway using a piezoelectric mechanical stimulator. We found that repeated MDMA administration increased the spontaneous firing rate but reduced both the magnitude and duration of whisker-evoked discharge in individual VPM thalamic neurons. The time course of drug action on neuronal firing patterns was generally consistent with fluctuations in neurotransmitter efflux as shown from our microdialysis studies. On the basis of these results, we propose that single use and repeated administration of MDMA may "distort," rather than enhance, tactile experiences in humans, in part, by disrupting normal spike firing patterns through somatosensory thalamic relay circuits.
3,4-亚甲二氧基甲基苯丙胺(MDMA)已知可增强触觉感知,这种作用是其作为娱乐性药物广受欢迎的原因之一。MDMA 对躯体感觉的影响的神经生理学基础尚不清楚。然而,MDMA 与血清素转运体(SERT)相互作用,随后增强血清素能神经传递是众所周知的。大鼠三叉神经躯体感觉系统接收来自背侧中缝核的血清素传入纤维。因为这些纤维表达 SERT,它们应该容易受到 MDMA 诱导的影响。我们发现,在重复 MDMA 治疗(每天 3 毫克/公斤,连续 4 天)后给予挑战剂量的 MDMA(3 毫克/公斤腹腔内注射),会引起长耳大白鼠腹后内侧核(VPM)的血清素和去甲肾上腺素外排,这是啮齿动物三叉神经躯体感觉通路的主要中继站。我们评估了重复 MDMA 给药对该区域单个神经元触发放电的潜在调节作用。在进行手术植入不锈钢八线多通道电极束后,我们使用压电机械刺激器激活胡须通路,同时记录单个细胞的尖峰串活动。我们发现,重复 MDMA 给药会增加自发放电率,但会降低单个 VPM 丘脑神经元的胡须诱发放电幅度和持续时间。药物作用于神经元放电模式的时间过程通常与微透析研究中显示的神经递质外排波动一致。基于这些结果,我们提出单次使用和重复使用 MDMA 可能会“扭曲”,而不是增强人类的触觉体验,部分原因是通过躯体感觉丘脑中继回路破坏正常的尖峰放电模式。